Alrutz Michael A

SVP AND GENERAL COUNSEL at CHIMERIX INC · on record since Feb 7, 2019
General Counsel at SYNAGEVA BIOPHARMA CORP · on record since Jan 31, 2008

Insider trading activity of Alrutz Michael A

Transactions on record: 127; since Apr 1, 2008

Open-market buys: 0

Open-market sells: 1; $7.2K

Companies traded: 2; last filing Apr 21, 2025

Figures computed from official regulatory filings — .

Companies where Alrutz Michael A has traded

CHIMERIX INC20 tx · $1.9M · Apr 21, 2025
SYNAGEVA BIOPHARMA CORP107 tx · Sep 24, 2010

Track record of Alrutz Michael A

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Alrutz Michael A

Co-insiders of Alrutz Michael A

14159 capital (GP), LLCSYNAGEVA BIOPHARMA CORP
14159, L.P.SYNAGEVA BIOPHARMA CORP
667, L.P.SYNAGEVA BIOPHARMA CORP
AKKARAJU SRINIVASSYNAGEVA BIOPHARMA CORP
ALEXION PHARMACEUTICALS INCSYNAGEVA BIOPHARMA CORP
ALTA EMBARCADERO BIOPHARMA PARTNERS III LLCCHIMERIX INC
A.M. Pappas Life Science Ventures IV LPCHIMERIX INC
Andriole Michael T.CHIMERIX INC
Baker Biotech Capital (GP), LLCSYNAGEVA BIOPHARMA CORP
Baker Biotech Capital II (A) (GP), LLCSYNAGEVA BIOPHARMA CORP
Baker Biotech Capital II (GP), LLCSYNAGEVA BIOPHARMA CORP
Baker Biotech Capital III (GP), LLCSYNAGEVA BIOPHARMA CORP
Baker Biotech Capital II (Z) (GP), LLCSYNAGEVA BIOPHARMA CORP
Baker Biotech Fund II (A), L.P.SYNAGEVA BIOPHARMA CORP
Baker Bros. Advisors (GP) LLCSYNAGEVA BIOPHARMA CORP
BAKER BROS. ADVISORS LPSYNAGEVA BIOPHARMA CORP
Baker Bros. Capital (GP), LLCSYNAGEVA BIOPHARMA CORP
Baker Bros. Investments II, L.P.SYNAGEVA BIOPHARMA CORP
Baker Bros. Investments, L.P.SYNAGEVA BIOPHARMA CORP
Baker Brothers Life Sciences LPSYNAGEVA BIOPHARMA CORP
BAKER FELIXSYNAGEVA BIOPHARMA CORP
BAKER JULIANSYNAGEVA BIOPHARMA CORP
Baker / Tisch Capital (GP), LLCSYNAGEVA BIOPHARMA CORP
Baker/Tisch Investments, LPSYNAGEVA BIOPHARMA CORP
Bazemore Robert BSYNAGEVA BIOPHARMA CORP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-45,750	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-165,000	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-176,000	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-178,000	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-170,000	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-131,250	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-128,550	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-15,000	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-200,000	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-250,000	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-135,000	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	Other	-216,689	8.55 USD	$1.9M	SEC
CHIMERIX INCListing unverified	Feb 14, 2025	Sell	-1,600	4.52 USD	$7.2K	SEC
CHIMERIX INCListing unverified	Jan 10, 2025	Award	41,667	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CHIMERIX INCListing unverified	Jan 10, 2025	AwardD (derivative)	250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CHIMERIX INCListing unverified	Feb 2, 2024	Award	21,875	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CHIMERIX INCListing unverified	Feb 2, 2024	AwardD (derivative)	131,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CHIMERIX INCListing unverified	Jan 19, 2023	AwardD (derivative)	128,550	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CHIMERIX INCListing unverified	Jan 19, 2023	Award	21,450	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CHIMERIX INCListing unverified	Feb 7, 2019	Award	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Sep 24, 2010	AwardD (derivative)	44,544	—	n/a (No price was disclosed in the filing)	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Jul 22, 2009	AwardD (derivative)	44,544	—	n/a (No price was disclosed in the filing)	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Jan 29, 2009	OtherD (derivative)	-740	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Jan 29, 2009	AwardD (derivative)	44,544	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Jan 29, 2009	AwardD (derivative)	3,322	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-45,750	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-165,000	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-176,000	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-178,000	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-170,000	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-131,250	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-128,550	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-15,000	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-200,000	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-250,000	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	OtherD (derivative)	-135,000	—	n/a (No price was disclosed in the filing)	SEC
CHIMERIX INCListing unverified	Apr 21, 2025	Other	-216,689	8.55 USD	$1.9M	SEC
CHIMERIX INCListing unverified	Feb 14, 2025	Sell	-1,600	4.52 USD	$7.2K	SEC
CHIMERIX INCListing unverified	Jan 10, 2025	Award	41,667	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CHIMERIX INCListing unverified	Jan 10, 2025	AwardD (derivative)	250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CHIMERIX INCListing unverified	Feb 2, 2024	Award	21,875	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CHIMERIX INCListing unverified	Feb 2, 2024	AwardD (derivative)	131,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CHIMERIX INCListing unverified	Jan 19, 2023	AwardD (derivative)	128,550	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CHIMERIX INCListing unverified	Jan 19, 2023	Award	21,450	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CHIMERIX INCListing unverified	Feb 7, 2019	Award	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Sep 24, 2010	AwardD (derivative)	44,544	—	n/a (No price was disclosed in the filing)	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Jul 22, 2009	AwardD (derivative)	44,544	—	n/a (No price was disclosed in the filing)	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Jan 29, 2009	OtherD (derivative)	-740	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Jan 29, 2009	AwardD (derivative)	44,544	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Jan 29, 2009	AwardD (derivative)	3,322	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC